| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |